Moderna (MRNA) stock Forecast for 2021 – 2025

Moderna (MRNA) stock Forecast for 2022 – 2026

Last update: November 27, 2022 (13:35)

Sector: Healthcare

The share price of Moderna, Inc. (MRNA) now

What analysts predict: $208.87

52-week high/low: $376.65 / $115.03

50/200 Day Moving Average: $140.66 / $148.93

This figure corresponds to the average price over the previous 50/200 days. For Moderna stocks, the 50-day moving average is the support level today.

For Moderna stocks, the 200-day moving average is the support level today.

Are you interested in Moderna, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Moderna stock price in 2022, 2023, 2024, 2025, 2026. How much will one Moderna share be worth in 2022 - 2026?

When should I take profit in Moderna stock? When should I record a loss on Moderna stock? What are analysts' forecasts for Moderna stock? What is the future of Moderna stock? We forecast Moderna stock performance using neural networks based on historical data on Moderna stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Moderna stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Moderna shares. This happens once a day.




Historical and forecast chart of Moderna stock

The chart below shows the historical price of Moderna stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Moderna stock price can be found in the table below.

Long-term forecasts by years.

Moderna daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 29 174.24 169.79 179.12 5.50
Nov 30 171.98 170.06 175.89 3.43
Dec 01 166.93 165.46 169.73 2.58
Dec 02 167.57 163.05 170.03 4.28
Dec 03 167.22 163.65 170.14 3.97
Dec 04 166.81 164.59 168.56 2.41
Dec 05 167.27 164.35 170.32 3.63
Dec 06 166.81 163.77 169.02 3.21
Dec 07 166.40 161.74 169.19 4.61
Dec 08 161.04 158.90 162.45 2.23
Dec 09 161.21 159.23 163.86 2.91
Dec 10 159.35 155.39 163.53 5.24
Dec 11 157.56 155.85 160.43 2.94
Dec 12 158.55 155.39 162.77 4.75
Dec 13 161.66 157.98 162.96 3.15
Dec 14 159.17 155.38 161.73 4.09
Dec 15 156.50 154.03 157.98 2.56
Dec 16 160.17 158.26 161.68 2.16
Dec 17 155.01 152.46 157.83 3.52
Dec 18 153.44 150.48 155.64 3.43
Dec 19 153.87 149.88 156.34 4.31
Dec 20 148.91 145.52 151.67 4.23
Dec 21 153.39 149.15 156.08 4.64
Dec 22 153.50 149.20 155.06 3.92
Dec 23 158.23 155.40 160.44 3.24
Dec 24 163.49 161.14 166.64 3.41
Dec 25 164.81 162.79 168.04 3.22
Dec 26 164.00 161.76 168.25 4.01
Dec 27 161.93 158.36 165.11 4.26
Dec 28 156.89 152.55 158.15 3.67

Moderna Daily Price Targets


Moderna Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $174.24.
Negative dynamics for Moderna shares will prevail with possible volatility of 5.209%.
Pessimistic target level: 169.79
Optimistic target level: 179.12

Moderna Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $171.98.
Negative dynamics for Moderna shares will prevail with possible volatility of 3.320%.
Pessimistic target level: 170.06
Optimistic target level: 175.89

Moderna Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $166.93.
Negative dynamics for Moderna shares will prevail with possible volatility of 2.513%.
Pessimistic target level: 165.46
Optimistic target level: 169.73

Moderna Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $167.57.
Positive dynamics for Moderna shares will prevail with possible volatility of 4.105%.
Pessimistic target level: 163.05
Optimistic target level: 170.03

Moderna Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $167.22.
Negative dynamics for Moderna shares will prevail with possible volatility of 3.818%.
Pessimistic target level: 163.65
Optimistic target level: 170.14

Moderna Stock Forecast 12-04-2022.

Forecast target price for 12-04-2022: $166.81.
Negative dynamics for Moderna shares will prevail with possible volatility of 2.355%.
Pessimistic target level: 164.59
Optimistic target level: 168.56

MRNA (MRNA) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 185.51 181.67 197.03 7.80

Moderna forecast for this year


Moderna Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $185.512. Pessimistic: $181.67. Optimistic: $197.03



Moderna (MRNA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 198.54 191.75 208.01 7.82
Feb 192.82 183.27 196.98 6.96
Mar 179.46 167.67 184.95 9.34
Apr 174.45 168.95 180.42 6.35
May 171.78 162.66 181.37 10.31
Jun 182.60 172.08 187.37 8.16
Jul 176.85 171.28 187.35 8.58
Aug 184.81 174.00 191.63 9.20
Sep 170.50 158.23 174.03 9.08
Oct 157.61 151.09 163.86 7.79
Nov 144.99 142.12 154.12 7.79
Dec 155.30 147.33 165.92 11.20

Moderna (MRNA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 158.79 149.50 163.94 8.80
Feb 166.37 155.14 178.34 13.01
Mar 172.21 166.16 177.32 6.29
Apr 169.42 158.29 179.02 11.58
May 170.79 161.87 174.63 7.31
Jun 170.02 160.84 173.39 7.24
Jul 176.45 171.05 185.50 7.79
Aug 168.19 158.20 175.15 9.68
Sep 174.09 165.94 178.95 7.27
Oct 177.85 166.17 184.42 9.90
Nov 176.73 165.60 181.50 8.76
Dec 192.32 181.42 196.30 7.58

Moderna (MRNA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 207.38 192.63 220.44 12.62
Feb 205.33 192.02 212.35 9.57
Mar 200.52 193.12 204.49 5.56
Apr 195.65 186.84 206.21 9.39
May 190.19 184.03 195.15 5.70
Jun 175.47 164.26 179.73 8.61
Jul 169.47 164.43 180.14 8.72
Aug 166.57 159.82 176.46 9.43
Sep 175.71 168.91 179.67 5.99
Oct 170.34 159.76 182.30 12.36
Nov 174.17 166.02 183.26 9.41
Dec 188.12 184.74 194.05 4.80

Moderna (MRNA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 189.65 176.16 199.54 11.72
Feb 187.09 177.82 191.97 7.37
Mar 170.58 166.44 180.41 7.74
Apr 172.89 168.06 180.82 7.06
May 173.51 164.30 177.41 7.39
Jun 176.01 171.73 185.51 7.43
Jul 170.31 165.09 177.36 6.91
Aug 167.55 157.14 172.98 9.15
Sep 178.25 172.48 189.00 8.74
Oct 172.48 164.56 184.43 10.77
Nov 180.70 172.08 193.39 11.02
Dec 196.64 187.97 203.54 7.65

Moderna information and performance

Moderna, Inc. is a biotech company based in Cambridge, Massachusetts that is engaged in drug discovery and RNA messenger drug development. The company is creating synthetic mRNA that can be injected into patients to help them create their own therapy.

Official site of the company

Moderna Address

200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US

Market Capitalization: 69 763 244 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 13 596 000 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 6.68

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 27.2

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.671
Quarterly Revenue Growth YOY: -0.323
Trailing PE: 6.68

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 28.25

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.031

Enterprise Value (EV) /Revenue

EV To EBITDA: 4.575

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 384180000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.